Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Coronavirus: Peace Corps Helps Launch Vaccination Campaign in Commune of Mantasoa The campaign is providing free, Johnson&Johnson vaccines – a donation from the U.S. government – to approximately 4,000 community members in the 11 Fokontany of Mantasoa

10/15/2021 | 10:59am EST

With the support of the U.S. Peace Corps, the Mantasoa CSB II launched its COVID-19 vaccination campaign yesterday. The campaign is providing free, Johnson&Johnson vaccines — a donation from the U.S. government — to approximately 4,000 community members in the 11 Fokontany of Mantasoa.

"It’s great that we can provide vaccinations to the people of Mantasoa since they have always supported our Peace Corps Training Center and Volunteers in Mantasoa," Dr. Tahiry Raveloson, a Peace Corps Medical Officer said.

The Peace Corps’ campaign began with training on how to conduct COVID-19 vaccine sensitization campaigns and run vaccine clinics. Nearly 20 community health workers (CHWs), all 11 Fokontany presidents, and 32 Peace Corps staff members participated.

"I want to thank the doctors, Agent Communautaires (ACs), and Peace Corps members who helped with the sensitization and the vaccination effort in each Fokontany," Rakotozafy Jean Pierre, the Mayor of Mantasoa said. "Thanks to that people are lining up to get vaccinated starting with the Chef of the Fokontany."

Through November, Peace Corps staff members and ACs will conduct outreach to promote the vaccine and answers questions and concerns. They will also run local vaccine clinics in each Fokontany. For example, Peace Corps and CSB staff conducted a vaccine clinic in Andrefanivorona on October 14 and another in Masombahiny on October 15.

Since the campaign’s launch on October 3, there has been a dramatic increase in vaccinations, with 233 people vaccinated to date.

"In the beginning, I was very hesitant about getting vaccinated, like almost everyone in the rural areas but after the sensitization and some information that I got about J&J, I got vaccinated," Rakotomalala Raymond, President of Fokontany Andrefanivorona, said.

This vaccination campaign represents just one of the ways the United States is supporting the global effort to expand and intensify the fight against COVID-19 abroad, respond to humanitarian crises exacerbated by COVID-19, and support a global recovery while preparing for future pandemic threats.

The U.S. government has been a leading partner to Madagascar, standing side-by-side like "mpirahalahy mianala" in responding to outbreaks of plague, measles, malaria, and COVID-19. The United States remains the largest single-country donor to Madagascar’s health sector, having provided $74.5 million in 2020 alone to strengthen the country’s health system.


Distributed by APO Group on behalf of U.S. Embassy in Madagascar & Comoros.

© African Press Organization, source Press Releases

All news about JOHNSON & JOHNSON
07:12aJOHNSON & JOHNSON : 4 Things to Know About RSV in the Time of COVID-19
PU
06:06aRwanda Receives 150,000 Johnson & Johnson Doses From Africa CDC
AQ
12/07Legend Biotech Submits New Drug Application for Myeloma CAR-T Therapy to Japanese Regul..
MT
12/07Johnson & Johnson Unit's Respiratory Syncytial Virus Vaccine Candidate Shows Up to 80% ..
MT
12/07J&J'S JANSSEN : Phase 2b RSV Vaccine Study Meets All Endpoints
DJ
12/07Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of t..
AQ
12/07CORONAVIRUS-MOZAMBIQUE : The United States Donates Additional 2 Million Johnson & Johnson ..
AQ
12/06CORONAVIRUS-MOZAMBIQUE : The United States Donates Additional 2 Million Johnson & Johnson ..
AQ
12/06Legend Biotech Submits New Drug Application for Myeloma Therapy to Japanese Regulator
MT
12/06Kaleido Biosciences Expands and Extends Collaboration With Janssen
MT
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 251 M - -
Net income 2021 22 542 M - -
Net Debt 2021 493 M - -
P/E ratio 2021 19,7x
Yield 2021 2,55%
Capitalization 430 B 430 B -
EV / Sales 2021 4,57x
EV / Sales 2022 4,25x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 163,36 $
Average target price 184,65 $
Spread / Average Target 13,0%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON3.80%430 061
ROCHE HOLDING AG19.17%324 115
PFIZER, INC.39.85%290 297
NOVO NORDISK A/S70.26%250 392
ELI LILLY AND COMPANY45.17%222 215
ABBVIE INC.13.40%214 815